Science Explorer Back to mapMap

Most cited papers from Center for Health Care Services

What are the most cited papers from Center for Health Care Services?

The most cited paper from Center for Health Care Services is "The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients" (Jill F. Hallin et al., 2019), with 1,328 citations. Next come "Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness" (592) and "Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma" (495).

Showing 50 of 60 papers. Every paper with more than 17 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients Jill F. Hallin et al. · Cancer Discovery Open access 28 Oct 2019 1,328
2 Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness Timothy D. Girard et al. · New England Journal of Medicine Open access 22 Oct 2018 592
3 Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma L. Keoki Williams, Manel Pladevall, Hugo Xi et al. · Journal of Allergy and Clinical Immunology Dec 2004 495
4 Frailty and Subsequent Disability and Mortality among Patients with Critical Illness Nathan E. Brummel, Susan P. Bell, Timothy D. Girard et al. · American Journal of Respiratory and Critical Care Medicine Open access 6 Mar 2017 344
5 Evidence of a Causal Role of Winter Virus Infection during Infancy in Early Childhood Asthma Pingsheng Wu, William D. Dupont, Marie R. Griffin et al. · American Journal of Respiratory and Critical Care Medicine Open access 5 Sep 2008 334
6 Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001–2015 Ashish Ambadas Deshmukh, Ryan Suk, Meredith S. Shiels et al. · JNCI Journal of the National Cancer Institute Open access 5 Nov 2019 331
7 First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆ Jiaxin Niu, Corinne Maurice‐Dror, D.H. Lee et al. · Annals of Oncology Open access 17 Nov 2021 298
8 Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis Christopher G. Hughes et al. · New England Journal of Medicine Open access 2 Feb 2021 292
9 Caring for Mental Illness in the United States: A Focus on Older Adults Ruth S. Klap, Kathleen Tschantz Unroe, Jürgen Unützer · American Journal of Geriatric Psychiatry Sep 2003 288
10 PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients Aung Naing et al. · Cancer Cell Open access Nov 2018 256
11 Long-term Cognitive and Psychological Outcomes in the Awakening and Breathing Controlled Trial James C. Jackson, Timothy D. Girard, Sharon M. Gordon et al. · American Journal of Respiratory and Critical Care Medicine Open access Jul 2010 256
12 Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors Anthony W. Tolcher, Mario Sznol, Siwen Hu‐Lieskovan et al. · Clinical Cancer Research 20 Jun 2017 238
13 Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study Maeve Aine Lowery et al. · ˜The œLancet. Gastroenterology & hepatology Open access 9 Jul 2019 223
14 Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study Funda Meric‐Bernstam et al. · The Lancet Oncology Open access 15 Nov 2022 198
15 Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma William D. Tap, Victor Manuel Villalobos, Gregory Michael Cote et al. · Journal of Clinical Oncology Open access 25 Mar 2020 165
16 Expanding the efficacy of Project UPLIFT: Distance delivery of mindfulness-based depression prevention to people with epilepsy. Nancy J. Thompson, Archna Patel, Linda M. Selwa et al. · Journal of Consulting and Clinical Psychology Open access 15 Dec 2014 155
17 Parental Misinterpretations of Over-the-Counter Pediatric Cough and Cold Medication Labels Nicole Lokker, Lee Michael Sanders, Eliana Miller Perrin et al. · PEDIATRICS Open access 26 May 2009 148
18 Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study Todd Hulgan, David W. Haas, Jonathan L. Haines et al. · AIDS 12 Aug 2005 148
19 Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients Jonathan S. Zager et al. · BMC Cancer Open access 5 Feb 2018 143
20 Fluoroquinolone Resistance in Mycobacterium tuberculosis : The Effect of Duration and Timing of Fluoroquinolone Exposure Rose A. Devasia, Amondrea Blackman, Tebeb S. Gebretsadik et al. · American Journal of Respiratory and Critical Care Medicine Open access 29 May 2009 139
21 PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer Hui Yu et al. · Journal of Thoracic Oncology Open access 16 Sep 2016 135
22 Antibiotic exposure in early infancy and risk for childhood atopy Christine Cole Johnson, Dennis R. Ownby, Sharon Hensley Alford et al. · Journal of Allergy and Clinical Immunology Jun 2005 132
23 Increasing Burden and Risk Factors for Bronchiolitis-Related Medical Visits in Infants Enrolled in a State Health Care Insurance Plan Kecia N. Carroll, Tebeb S. Gebretsadik, Marie R. Griffin et al. · PEDIATRICS Open access Jul 2008 129
24 Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial Aung Naing et al. · The Lancet Oncology Open access 25 Sep 2019 120
25 Acute myeloid leukemia management and research in 2025 Hagop M. Kantarjian, Courtney Denton Dinardo, Tapan Mahendra Kadia et al. · CA A Cancer Journal for Clinicians Open access 10 Dec 2024 114
26 Delirium and Sedation Recognition Using Validated Instruments: Reliability of Bedside Intensive Care Unit Nursing Assessments from 2007 to 2010 Eduard Eric Vasilevskis, Alessandro Morandi, Leanne M. Boehm et al. · Journal of the American Geriatrics Society Open access Nov 2011 110
27 Understanding the error of our ways: Mapping the concepts of validity and reliability Patricia A. Higgins, Andrew J. Straub · Nursing Outlook 2006 106
28 Self-Management Behaviors, Racial Disparities, and Glycemic Control Among Adolescents With Type 2 Diabetes Russell L. Rothman, Shelagh A. Mulvaney, Tom A. Elasy et al. · PEDIATRICS Apr 2008 88
29 American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care Nathan A. Pennell et al. · Journal of Clinical Oncology Open access 8 Dec 2020 87
30 Pathogenic tau accelerates aging-associated activation of transposable elements in the mouse central nervous system Paulino Ramirez, Gabrielle Zuniga, Wenyan Sun et al. · Progress in Neurobiology Open access 18 Oct 2021 79
31 Race-ethnicity, crime, and other factors associated with adherence to inhaled corticosteroids L. Keoki Williams, Christine L.M. Joseph, Edward L. Peterson et al. · Journal of Allergy and Clinical Immunology 3 Nov 2006 79
32 Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases Chu Chen · Pharmacology & Therapeutics Open access 24 Mar 2023 73
33 Is Anaemia a Risk Factor for Delirium in an Acute Geriatric Population? Etienne Joosten, Joke Lemiengre, Tine Nelis et al. · Gerontology 2006 69
34 Caring for Mental Illness in the United States: A Focus on Older Adults R. Klap · American Journal of Geriatric Psychiatry 23 Sep 2003 66
35 Race-Ethnic Differences in Factors Associated with Inhaled Steroid Adherence among Adults with Asthma Karen E. Wells, Manel Pladevall, Edward L. Peterson et al. · American Journal of Respiratory and Critical Care Medicine Open access 10 Oct 2008 66
36 Applying Lean Methods to Improve Quality and Safety in Surgical Sterile Instrument Processing C. Craig Blackmore, Robbi Bishop, Samuel Luker et al. · The Joint Commission Journal on Quality and Patient Safety Mar 2013 57
37 Profiles of Patients Who Experienced a Late Acute Rejection Due to Nonadherence with Immunosuppressive Therapy Sabina De Geest, Philip Moons, Fabienne Dobbels et al. · The Journal of Cardiovascular Nursing Oct 2001 54
38 CD4 Lymphocyte Percentage Predicts Disease Progression in HIV‐Infected Patients Initiating Highly Active Antiretroviral Therapy with CD4 Lymphocyte Counts >350 Lymphocytes/mm3 Todd Hulgan, Stephen P Raffanti, Asghar Kheshti et al. · The Journal of Infectious Diseases Open access 19 Aug 2005 53
39 Integrating Geriatric Principles into Critical Care Medicine: The Time is Now Nathan E. Brummel, Lauren E. Ferrante · Annals of the American Thoracic Society Open access 3 Jan 2018 51
40 Differences in Childhood Sexual Abuse Experience Between Adult Hispanic and Anglo Women in a Primary Care Setting David A. Katerndahl, Sandra K. Burge, Nancy D. Kellogg et al. · Journal of Child Sexual Abuse 18 May 2005 50
41 Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial Henriette U. Balinda, William Kelly, Virginia Kaklamani et al. · Nature Communications Open access 7 Aug 2024 46
42 Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study Komal L. Jhaveri et al. · Journal of Clinical Oncology Open access 6 Sep 2024 45
43 Outcome and Utilization Differences for Older Persons with Stroke in HMO and Fee‐for‐Service Systems Andrew M. Kramer, Jacqueline Cahill Kowalsky, Michael Lin et al. · Journal of the American Geriatrics Society Jul 2000 43
44 Pegilodecakin as monotherapy or in combination with anti‐PD ‐1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I study Nizar M. Tannir, Kyriakos P. Papadopoulos, Deborah J. L. Wong et al. · International Journal of Cancer Open access 12 Mar 2021 40
45 Prognostication and Goals of Care Decisions in Severe Traumatic Brain Injury: A Survey of The Seattle International Severe Traumatic Brain Injury Consensus Conference Working Group Buse Sarıgül et al. · Journal of Neurotrauma Open access 18 Mar 2023 39
46 Effective Outpatient Drug Treatment Organizations: Program Features and Selection Effects William Cass McCaughrin, Richard H. Price · International Journal of the Addictions 1992 36
47 Using Lean “Automation with a Human Touch” to Improve Medication Safety: A Step Closer to the “Perfect Dose” Joan M. Ching, Barbara Williams, Lori M. Idemoto et al. · The Joint Commission Journal on Quality and Patient Safety Aug 2014 35
48 Oral quinolones in hospitalized patients: an evaluation of a computerized decision support intervention* Todd Hulgan, S. Trent Rosenbloom, Fred R. Hargrove et al. · Journal of Internal Medicine 13 Sep 2004 35
49 Are There Race/Ethnicity Differences in Outpatient Congestive Heart Failure Management, Hospital Use, and Mortality Among an Insured Population? Jennifer Elston Lafata, Manel Pladevall, George Divine et al. · Medical Care 22 Jun 2004 33
50 Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium the Australian Ovarian Cancer Study Group et al. · Cancer Causes & Control Open access 23 Mar 2019 30

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.